Friday 6 November 2026 Export HAE’s income statement to Excel — free account

Haemonetics Corporation

Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.

Revenue: +9.30%
EPS: +25.9%
Free cash flow: +20.4%
Total debt: +21.0%

Quarter to September 2026, against a year earlier

119.97 4.14 −3.34%

Follow HAE

Alert me

Market cap: $5.7B
P/E: 54.5×
Fwd P/E: 30.2×
Dividend yield: —
F-score: 6/9
Altman Z: 2.21
Beneish M: −2.81
Dividend safety: n/a

Overview

Haemonetics Corporation (HAE) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Haemonetics Corporation (HAE) trades at a P/B ratio of 6.2×. Over the past ten years it has ranged from 1.8× (May 2016) to 12.0× (August 2019); the current reading is higher than 75% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HAE/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Haemonetics Corporation P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HAE/metrics/pb-ratio">Haemonetics Corporation (HAE) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2026	3.3×	(14.31%)
FY2025	3.9×	(13.00%)
FY2024	4.5×	(12.82%)
FY2023	5.1×	19.30%
FY2022	4.3×	(44.01%)
FY2021	7.7×	(10.63%)
FY2020	8.6×	24.25%
FY2019	6.9×	36.88%
FY2018	5.1×	79.01%
FY2017	2.8×	14.52%

Period	P/B ratio	Change
Sep 2026	5.3×	31.21%
Jun 2026	4.1×	21.71%
Mar 2026	3.3×	(18.85%)
Dec 2025	4.1×	50.64%
43 more quarters	Free account

Against its own ten years

Low 1.8× High 12.0×

Ten-year median 4.5×

Current reading's percentile 73

Company	P/B ratio
BIO Bio-Rad Laboratories, Inc. compare	1.3×
BIO.B Bio-Rad Laboratories, Inc. compare	1.3×
ITGR Integer Holdings Corporation compare	2.5×
BRKR Bruker Corporation compare	3.7×
LIVN LivaNova PLC compare	3.8×
AXGN AxoGen, Inc. compare	5.4×
HAE Haemonetics Corporation	6.2×
TXG 10x Genomics compare	9.2×
IRTC iRhythm Holdings, Inc. compare	24.4×
Medical Devices industry median	2.5×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Haemonetics Corporation (HAE) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on HAE

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on HAE

Stockrow Weekly